Capsugel has launched its Dosage Form Solutions (DFS) business unit focused on lipid-based formulations, as well as continued expansion of its targeted release capsules offerings. Amit Patel will serve as president of the DFS unit from Capsugel’s headquarters in Morristown, NJ. Mr. Patel has extensive experience in the pharmaceutical industry, including generics and specialty pharmaceuticals.
“With the launch of the new DFS business unit, Capsugel builds on its heritage of delivering innovative, quality products and services in hard capsules, by advancing our expertise in product formulation and commercial finished product manufacturing,” said Guido Driesen, president and chief executive officer of Capsugel. “DFS is well-positioned to help address our customers’ most pressing dosage form challenges of existing and new nutritional and pharmaceutical products.”
DFS has operations in North America, Europe and Asia, and serves leading and emerging specialty, branded and generic pharmaceutical customers, as well as the consumer health and nutritional segments.
See our interview with Mr. Driesen in the Jan/Feb issue of Contract Pharma!